Chan. Kim, et.al., Vascular RhoJ is an effective and selective target for tumor angiogenesis and vascular disruption., Cancer cell, 2014, 25

http://rdf.ncbi.nlm.nih.gov/pubmed/24434213

Chan. Kim, et.al., Vascular RhoJ is an effective and selective target for tumor angiogenesis and vascular disruption., Cancer cell, 2014, 25

pubmed

allele

http://purl.org/net/cito/citesAsAuthority

• Rhoj<tm1.1Auem>
  http://metadb.riken.jp/db/mgi_rdf/MGI:5608668
• Rhoj<tm1.2Auem>
  http://metadb.riken.jp/db/mgi_rdf/MGI:5608669

class

http://purl.org/net/cito/citesAsAuthority

• Rhoj<tm1.1Auem>
  http://metadb.riken.jp/db/mgi_rdf/MGI:5608668
• Rhoj<tm1.2Auem>
  http://metadb.riken.jp/db/mgi_rdf/MGI:5608669

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• decreased metastatic potential_Rhoj<tm1.2Auem>/Rhoj<tm1.2Auem>
  http://metadb.riken.jp/0001273B6CgRhojtm12AuemRhojtm12AuemRhojtm12AuemRhojtm12Auem
• decreased metastatic potential_Rhoj<tm1.2Auem>/Rhoj<tm1.2Auem>,Tg(MMTV-PyVT)634Mul/0
  http://metadb.riken.jp/0001273IC57BL6CBAJNCrljFVBNRhojtm12AuemRhojtm12AuemTgMMTVPyVT634Mul0TgMMTVPyVT634MulRhojtm12Auem
• internal hemorrhage_Rhoj<tm1.2Auem>/Rhoj<tm1.2Auem>
  http://metadb.riken.jp/0001634B6CgRhojtm12AuemRhojtm12AuemRhojtm12AuemRhojtm12Auem
• internal hemorrhage_Rhoj<tm1.1Auem>/Rhoj<tm1.1Auem>,Tg(Cdh5-cre/ERT2)1Rha/0
  http://metadb.riken.jp/0001634IC57BL6CBAJNCrljRhojtm11AuemRhojtm11AuemTgCdh5creERT21Rha0Rhojtm11AuemTgCdh5creERT21Rha
• delayed wound healing_Rhoj<tm1.2Auem>/Rhoj<tm1.2Auem>,Tg(MMTV-PyVT)634Mul/0
  http://metadb.riken.jp/0002908IC57BL6CBAJNCrljFVBNRhojtm12AuemRhojtm12AuemTgMMTVPyVT634Mul0TgMMTVPyVT634MulRhojtm12Auem
• decreased tumor growth/size_Rhoj<tm1.2Auem>/Rhoj<tm1.2Auem>
  http://metadb.riken.jp/0003447B6CgRhojtm12AuemRhojtm12AuemRhojtm12AuemRhojtm12Auem
他9件を見る
• decreased tumor growth/size_Rhoj<tm1.2Auem>/Rhoj<tm1.2Auem>,Tg(MMTV-PyVT)634Mul/0
  http://metadb.riken.jp/0003447IC57BL6CBAJNCrljFVBNRhojtm12AuemRhojtm12AuemTgMMTVPyVT634Mul0TgMMTVPyVT634MulRhojtm12Auem
• decreased tumor growth/size_Rhoj<tm1.1Auem>/Rhoj<tm1.1Auem>,Tg(Cdh5-cre/ERT2)1Rha/0
  http://metadb.riken.jp/0003447IC57BL6CBAJNCrljRhojtm11AuemRhojtm11AuemTgCdh5creERT21Rha0Rhojtm11AuemTgCdh5creERT21Rha
• abnormal tumor morphology_Rhoj<tm1.2Auem>/Rhoj<tm1.2Auem>
  http://metadb.riken.jp/0003448B6CgRhojtm12AuemRhojtm12AuemRhojtm12AuemRhojtm12Auem
• abnormal tumor morphology_Rhoj<tm1.1Auem>/Rhoj<tm1.1Auem>,Tg(Cdh5-cre/ERT2)1Rha/0
  http://metadb.riken.jp/0003448IC57BL6CBAJNCrljRhojtm11AuemRhojtm11AuemTgCdh5creERT21Rha0Rhojtm11AuemTgCdh5creERT21Rha
• increased physiological sensitivity to xenobiotic_Rhoj<tm1.2Auem>/Rhoj<tm1.2Auem>
  http://metadb.riken.jp/0008873B6CgRhojtm12AuemRhojtm12AuemRhojtm12AuemRhojtm12Auem
• abnormal tumor vascularization_Rhoj<tm1.2Auem>/Rhoj<tm1.2Auem>
  http://metadb.riken.jp/0010144B6CgRhojtm12AuemRhojtm12AuemRhojtm12AuemRhojtm12Auem
• abnormal tumor vascularization_Rhoj<tm1.2Auem>/Rhoj<tm1.2Auem>,Tg(MMTV-PyVT)634Mul/0
  http://metadb.riken.jp/0010144IC57BL6CBAJNCrljFVBNRhojtm12AuemRhojtm12AuemTgMMTVPyVT634Mul0TgMMTVPyVT634MulRhojtm12Auem
• abnormal tumor vascularization_Rhoj<tm1.1Auem>/Rhoj<tm1.1Auem>,Tg(Cdh5-cre/ERT2)1Rha/0
  http://metadb.riken.jp/0010144IC57BL6CBAJNCrljRhojtm11AuemRhojtm11AuemTgCdh5creERT21Rha0Rhojtm11AuemTgCdh5creERT21Rha
• decreased mammary gland tumor incidence_Rhoj<tm1.2Auem>/Rhoj<tm1.2Auem>,Tg(MMTV-PyVT)634Mul/0
  http://metadb.riken.jp/0010269IC57BL6CBAJNCrljFVBNRhojtm12AuemRhojtm12AuemTgMMTVPyVT634Mul0TgMMTVPyVT634MulRhojtm12Auem